Customer Center
Login | Register
 
 

Clinical

Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
 
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
 
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
 
Learn More

Luminex® Blog

ARIES® System Provides Excellent Sensitivity and Specificity for HSV 1&2 Testing

Mayo Clinic study compares ARIES® HSV 1&2 Assay with Roche and Hologic assays/platforms

A new publication from scientists at the Mayo Clinic reports results of the first comparison of three automated molecular diagnostic platforms for detecting and differentiating herpes simplex virus types 1 and 2. We were pleased to see that the ARIES® System was included and delivered the best combination of sensitivity and specificity…”

Continue Reading…

We Are Luminex

 
We Are Luminex

 

At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.

Watch more videos >

Luminex on Twitter


Read about Sherry Dunbar's 18-year history with the company in the latest edition of #FacesofLuminex.… https://t.co/oEoPqHk6XQ
h J R
Researchers find increased rates of #Cdiff in travelers: https://t.co/rsa9tFPVt0 by @Contagion_Live
h J R

Latest News

April 20
Luminex Corporation To Present At Bank Of America Merrill Lynch 2017 Health Care Conference

April 10
Luminex Corporation First Quarter Earnings Release Scheduled for May 1, 2017

March 1
Luminex Corporation To Present At The Barclays Global Healthcare Conference

February 21
Luminex Corporation Announces Initiation of Cash Dividend

February 6
Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results

January 9
Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance; To Present at 35th Annual J.P. Morgan Healthcare Conference

Events

ECCMID
22-25 April
Vienna, AT

Labvolution/Biotechnica
16-18 May
Hannover, DE

Scottish Diagnostic Virology Group Meeting
26 May
Stirling, UK

Drug Discovery Summit
12-13 June
Berlin, DE

Microbiology Meeting
31 August-1 September
Switzerland